Project Grant F32DC024200
- The National Institute on Deafness and Other Communication Disorders awarded Vanderbilt University Medical Center $136,911 on February 15, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to conduct a clinical trial feasibility study characterizing cognitive-linguistic and auditory processing profiles in adult cochlear implant recipients with poor speech recognition outcomes and to determine the feasibility of auditory and cognitive intervention...
- The National Institute on Deafness and Other Communication Disorders awarded Vanderbilt University Medical Center $232,750 on September 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to evaluate genetic risk for rhythm impairment as a predictor of language development across the lifespan. The recipient will conduct retrospective, longitudinal, and targeted follow-up studies using interdisciplinary methodologies from communication sciences and...
- The National Institute on Deafness and Other Communication Disorders awarded The Johns Hopkins University $194,270 on May 11, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to investigate the development of auditory thalamocortical circuits and how they are altered in cases of congenital deafness. The project will establish a foundational understanding of how the thalamus and auditory cortex develop and mature through sensory experience, with...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $445,956 Project Grant award on August 7, 2025, from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The project, titled "Molecular and Physiologic Architecture of the Human Inner Ear," will be completed by July 31, 2027. This award funds the establishment of a collaborative molecular...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded Vanderbilt University Medical Center $729,157 on September 4, 2026, under the Aging Research program (CFDA 93.866) to characterize age-specific communication and psychosocial outcomes in adults with cochlear implants across the adult lifespan. The project addresses a gap in understanding how age affects outcomes in cochlear implant recipients. Current clinical measures fail to capture the real-world...
- The National Institute on Deafness and Other Communication Disorders awarded The Johns Hopkins University $654,879 on July 17, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to investigate cortical representations of electrical stimulation in cochlear implant recipients. The research elucidates fundamental neural coding and plasticity mechanisms responsible for cortical processing of cochlear implant signals. The project employs optical imaging and...
- The National Institute on Deafness and Other Communication Disorders awarded Baylor College of Medicine $684,114 on August 21, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to investigate how the dorsal cochlear nucleus, the brainstem circuit responsible for localizing sounds in the vertical plane, integrates multimodal sensory inputs—including ear movement, head movement, and neuromodulatory signals reflecting brain state—during active behavior...
- The National Institute on Deafness and Other Communication Disorders awarded Massachusetts Eye and Ear Infirmary $701,848 on July 10, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to investigate auditory encoding, perception, and plasticity in the deaf adult brain following inner ear gene therapy. The project, designated R01DC023999, runs through May 31, 2031, and is performed in Boston, Massachusetts. The research employs a multidisciplinary...
- The National Institute on Deafness and Other Communication Disorders awarded the University of Pittsburgh $664,448 on September 1, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The award funds investigation of how heterogeneous neural responses in auditory cortex and secondary motor cortex contribute to auditory learning and perception. The project combines large-scale neural recordings with optogenetic manipulations to examine how local auditory...
- The National Institute on Deafness and Other Communication Disorders awarded the University of Wisconsin - Madison $1,166,250 on September 16, 2025, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to investigate cortical population coding and network effects of cochlear implant stimulation during behavioral tasks. The research addresses gaps in understanding why cochlear implant outcomes vary significantly among users, despite over one million people...
The National Institute on Deafness and Other Communication Disorders awarded Vanderbilt University Medical Center $158,696 on December 31, 2026, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to identify genetic biomarkers of central auditory structures that predict individual cochlear implant outcomes in adults with moderate to profound hearing loss. The fellowship research addresses the gap that 80 percent of variance in speech recognition outcomes after implantation remains unexplained by existing clinical models, which focus primarily on peripheral auditory factors rather than central auditory pathway contributions. The investigator will conduct two aims: determining the impact of genetic variation affecting central auditory structures on post-operative speech recognition in adult cochlear implant users, and determining the impact of variants in genes of neurotrophic factors broadly expressed throughout the peripheral and central auditory system, with the hypothesis that pathogenic variants in both categories are associated with poorer implant-aided outcomes. The fellowship will provide training in gene expression analysis, variant annotation, and machine learning to establish an independent research program leveraging genetics to optimize hearing rehabilitation. Identification of these biomarkers will enable precision medicine approaches to device programming, rehabilitation, and counseling strategies. Performance occurs at Forest Hills, Tennessee, with a period extending from December 31, 2026, through June 30, 2029. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 7/1/26 | ||
| Not listed | $79.3k | 7/1/26 | ||
| Not listed | $79.3k | 7/1/26 |